LHC Group, Inc. Profile Avatar - Palmy Investing

LHC Group, Inc.

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Servic…
Medical - Care Facilities
US, Lafayette [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q3 Q4 Δ in %
EV/EBITDA 142.91 286.99 118.15
Graham Fair Price -34.33 16.96 25.83
PEG 1.09 1.16 1.15
Price/Book -0.98 3.10 3.13
Price/Cash Flow -73.42 143.13 538.46
Prices/Earnings 128.55 -165.13 72.25
Price/Sales 2.03 8.85 8.67
Price/FCF -73.42 143.13 538.46
Naive Interpretation member
01 - Valuation · Bad
Fundamentals

Profitability

Metric Q3 Q4 Δ in %
Gross Profit Margin -4.78 0.38 0.40
Operating Margin -54.71 0.03 0.07
ROA -56.55 < 0.005 < 0.005
ROE 0.01 < 0.005 -56.67
ROIC 0.01 < 0.005 -43.29
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q3 Q4 Δ in %
Debt QOQ < 0.005 -0.03 71.79
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ 0.52 -0.56 8.13
EPS QOQ 0.63 -1.42 126.08
FCF QOQ -0.84 2.71 223.15
Revenue QOQ < 0.005 -0.03 2499.95
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q3 Q4 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 228.87 213.62 -6.66
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.35 0.35 -0.26
Quick Ratio 1.23 1.19 -3.43
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q3 Q4 Δ in %
Book Value 52.36 52.24 -0.23
Cash 0.34 0.59 70.37
Capex -0.10 -0.18 -79.20
Free Cash Flow 0.30 1.13 271.68
Revenue 18.87 18.28 -3.17
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q3 Q4 Δ in %
Current Ratio 1.45 1.41 -3.30
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 16.98 41.13 142.26
Naive Interpretation Member
06 - Financial Health · Weak
End of LHCG's Analysis
CIK: 1303313 CUSIP: 50187A107 ISIN: US50187A1079 LEI: - UEI: -
Secondary Listings
LHCG has no secondary listings inside our databases.